Will a vaccine for COVID-19 be safe? Animal testing, human clinical trials and post-approval surveillance give us good grounds to believe that a future approved vaccine will work and be safe.
Academic rigor, journalistic flair
Articles on FDA approval process
Displaying 21 - 23 of 23 articles
The rushed emergency approval for a treatment that might help COVID-19 patients has raised questions: Is the FDA abandoning its own guidelines?
As drug prices soar, consumers look for cheaper generics. A recent study showed safety issues in some generics made abroad, however, suggesting that the FDA’s honor system may not be enough to ensure safety.
Top contributors
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Joel Lexchin is a Friend of The Conversation.
Professor Emeritus of Health Policy and Management, York University, Canada
-
Professor of medicine, epidemiology & biostatistics, and philosophy, Western University
-
Professor of Law, Villanova School of Law
-
James P. Jimirro Professor of Media Effects, Co-Director, Media Effects Research Laboratory, & Director, Center for Socially Responsible AI, Penn State
-
Assistant Professor in Health Promotion and Policy, UMass Amherst, UMass Amherst
-
Director of Tobacco Prevention and Evaluation, University of North Carolina at Chapel Hill
-
University Research Lecturer, Nuffield Department of Primary Care Health Sciences, University of Oxford
-
Professor of Law, Georgia State University
-
Étudiant au doctorat en psychologie, Université du Québec à Montréal (UQAM)
-
Professor of pediatrics, microbiology and immunology, and environmental sciences and engineering, University of North Carolina at Chapel Hill
-
Associate Professor of Philosophy and Core Member of the Rotman Institute of Philosophy, Western University
-
Research Specialist, University of Michigan
-
Associate Professor of Public Policy, University of Maryland, Baltimore County
-
Assistant Professor of Philosophy and Bioethicist, University of Cincinnati
